PMC:7228307 / 41941-42059 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7228307","sourcedb":"PMC","sourceid":"7228307","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7228307","text":"us, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles. First, i","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"720","span":{"begin":53,"end":57},"obj":"Gene"}],"attributes":[{"id":"A720","pred":"tao:has_database_id","subj":"720","obj":"Gene:2213"},{"subj":"720","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T753","span":{"begin":53,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"attributes":[{"subj":"T753","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T218","span":{"begin":58,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A218","pred":"chebi_id","subj":"T218","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"},{"subj":"T218","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"720","span":{"begin":53,"end":57},"obj":"Gene"}],"attributes":[{"id":"A720","pred":"pubann:denotes","subj":"720","obj":"Gene:2213"},{"subj":"720","pred":"source","obj":"LitCovid-sample-Pubtator"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#a493ec","default":true},{"id":"LitCovid-PD-CLO","color":"#9bec93"},{"id":"LitCovid-PD-CHEBI","color":"#ec93b5"},{"id":"LitCovid-sample-Pubtator","color":"#93cfec"}]}]}}